3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Glioblastoma
5
Carcinoma, Non-Small-Cell Lung
5
Squamous Cell Carcinoma of Head and Neck
4
Rectal Neoplasms
4
Neoplasms
4
Head and Neck Neoplasms
4
Colorectal Neoplasms
4
Stomach Neoplasms
3
Glioma
3
Esophageal Neoplasms
3
Carcinoma, Hepatocellular
3
Breast Neoplasms
3
Brain Neoplasms
3
Astrocytoma
3
Sarcoma
2
Pancreatic Neoplasms
2
Osteosarcoma
2
Lung Neoplasms
2
Carcinoma, Squamous Cell
2
Wilms Tumor
1
Urinary Bladder Neoplasms
1
Skin Neoplasms
1
Sinonasal Squamous Cell Carcinoma
1
Rhabdomyosarcoma
1
Recurrence
1
Radiation Injuries
1
Prostatic Neoplasms
1
Prostate Adenocarcinoma
1
Postoperative Complications
1
Pilonidal Sinus
1
Interventions
Imatinib Mesylate
6
Sunitinib
4
ripretinib
2
regorafenib
2
Specimen Handling
2
Paclitaxel
2
Magnetic Resonance Spectroscopy
2
IDRX-42
2
trastuzumab deruxtecan
1
pemigatinib
1
olverembatinib
1
envafolimab
1
atezolizumab
1
apatinib
1
Temozolomide
1
Surgical Instruments
1
Sorafenib
1
Rogaratinib
1
Nivolumab
1
Midazolam
1
Laparoscopy
1
Ipilimumab
1
Cyclophosphamide
1
CTLA-4 Antigen
1
Blood Specimen Collection
1
Biopsy
1
4-Aminopyridine
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Gastrointestinal Stromal Tumors
×
Surgical Procedures, Operative
×
90 days
×
Clear all
No trials found.